Disease Site Groups

UF Heath Cancer Center has 12 Disease Site Groups that consist of both research and clinical leaders.  Each Disease Site Group is charged with developing and maintaining a portfolio of trials that brings forward scientific hypotheses developed in the Cancer Center Research Programs and is relevant to the Cancer Center’s catchment area.

All newly proposed interventional trials must be endorsed first by the appropriate Disease Site Group prior to SRMC submission by completing the DSG Submission Form.


Disease Site GroupsResearch Leader(s)Clinical Leader(s)
GastrointestinalThomas George, M.D., FACP Steven J. Hughes, M.D.
GenitourinaryPaul L. Crispen, M.D.Robert Zlotecki, M.D., Ph.D.
ThoracicFredric J. Kaye, M.D.Hiren Mehta, M.D.
Tiago Machuca, M.D., Ph.D.
GynecologicMerry Jennifer Markham, M.D.Jackie Castagno, M.D.
Sarcoma/CutaneousChristiana M. Shaw, M.D.Andre Spiguel, M.D.
Joanne Lagmay, M.D.
BreastKaren Daily, D.O.Lisa Spiguel, M.D.
Natalie Lockney, M.D.
NeurologyDavid Tran, M.D.Maryam Rahman, M.D.
Head and NeckNatalie L. Silver, M.D., M.S.Peter Dziegielewski, M.D.
Robert J. Amdur, M.D.
Hematologic MalignanciesNosha Farhadfar, M.D. Randy A. Brown, M.D.
Jack W. Hsu, M.D.
Pediatrics Sridharan Gururangan, FRCP (Edin.)William B. Slayton, M.D.
Experimental Therapeutics GroupThomas George, M.D., FACP
David DeRemer, Pharm.D, FCCP, BCOP
Cancer Population SciencesDiana Wilkie, Ph.D., RN, FAAN
Janice Krieger, Ph. D.